carmustine and carbon monoxide

carmustine has been researched along with carbon monoxide in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cairncross, G; Eisenhauer, E; Gertler, S; Perry, J; Wainman, N; Webster, M	1
Dolan, E; Gajewski, TF; Gerson, SL; Lin, S; Liu, L; Sosman, J; Vokes, EE	1

Trials

2 trial(s) available for carmustine and carbon monoxide

Article	Year
Phase II trial of SarCNU in malignant glioma: unexpected pulmonary toxicity with a novel nitrosourea: a phase II trial of the national cancer institute of canada clinical trials group. Investigational new drugs, 2005, Volume: 23, Issue:6 Topics: Academies and Institutes; Adult; Aged; Antineoplastic Agents; Astrocytoma; Canada; Carbon Monoxide; Carmustine; Central Nervous System Neoplasms; Female; Glioblastoma; Humans; Lung; Male; Middle Aged; Neoplasm Recurrence, Local; Pulmonary Diffusing Capacity	2005
Phase II trial of the O6-alkylguanine DNA alkyltransferase inhibitor O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea in advanced melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Nov-01, Volume: 11, Issue:21 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carbon Monoxide; Carmustine; Cohort Studies; Disease Progression; Female; Guanine; Humans; Leukocytes, Mononuclear; Male; Melanoma; Middle Aged; Neoplasm Metastasis; O(6)-Methylguanine-DNA Methyltransferase; Time Factors; Treatment Outcome	2005

Article

Year

Phase II trial of SarCNU in malignant glioma: unexpected pulmonary toxicity with a novel nitrosourea: a phase II trial of the national cancer institute of canada clinical trials group.

Investigational new drugs, 2005, Volume: 23, Issue:6

Topics: Academies and Institutes; Adult; Aged; Antineoplastic Agents; Astrocytoma; Canada; Carbon Monoxide; Carmustine; Central Nervous System Neoplasms; Female; Glioblastoma; Humans; Lung; Male; Middle Aged; Neoplasm Recurrence, Local; Pulmonary Diffusing Capacity

2005

Phase II trial of the O6-alkylguanine DNA alkyltransferase inhibitor O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea in advanced melanoma.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Nov-01, Volume: 11, Issue:21

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carbon Monoxide; Carmustine; Cohort Studies; Disease Progression; Female; Guanine; Humans; Leukocytes, Mononuclear; Male; Melanoma; Middle Aged; Neoplasm Metastasis; O(6)-Methylguanine-DNA Methyltransferase; Time Factors; Treatment Outcome

2005